TITLE

Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type

AUTHOR(S)
Tato, R E; Frank, A; Hernanz, A
PUB. DATE
September 1995
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Sep1995, Vol. 59 Issue 3, p280
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
No abstract available.
ACCESSION #
66100946

 

Related Articles

  • Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer's disease. Guo, Liang-Hao; Alexopoulos, Panagiotis; Perneczky, Robert // European Archives of Psychiatry & Clinical Neuroscience;Oct2013, Vol. 263 Issue 7, p553 

    The main objective of the study was to validate the findings of previous cerebrospinal fluid (CSF) proteomic studies for the differentiation between Alzheimer's disease (AD) dementia and physiological ageing. The most consistently significant proteins in the separation between AD dementia versus...

  • Cerebrospinal Fluid Markers in Differential Diagnosis of Alzheimer's Disease and Vascular Dementia. Boban, Marina; Grbić, Kristina; Mladinov, Mihovil; Hof, Patrick R.; Süßmair, Christine; Ackl, Nibal; Stanić, Gabrijela; Bader, Benedikt; Danek, Adrian; Šimić, Goran // Collegium Antropologicum;Jan2008 Supplement 1, Vol. 32, p31 

    Alzheimer's disease (AD) and vascular dementia (VaD) are the two most common causes of dementia in old people. They remain difficult to differentiate in practice because of lack of sensitivity and specificity of current clinical diagnostic criteria. Recent molecular and cellular advancements...

  • Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia. Skillbäck, Tobias; Farahmand, Bahman Y.; Rosén, Christoffer; Mattsson, Niklas; Nägga, Katarina; Kilander, Lena; Religa, Dorota; Wimo, Anders; Winblad, Bengt; Schott, Jonathan M.; Blennow, Kaj; Eriksdotter, Maria; Zetterberg, Henrik // Brain: A Journal of Neurology;Sep2015, Vol. 138 Issue 9, p2716 

    Progressive cognitive decline in combination with a cerebrospinal fluid biomarker pattern of low levels of amyloid-β1-42 and high levels of total tau and phosphorylated tau is typical of Alzheimer's disease. However, several neurodegenerative disorders may overlap with Alzheimer's disease...

  • Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia. Skillbäck, Tobias; Farahmand, Bahman Y; Rosén, Christoffer; Mattsson, Niklas; Nägga, Katarina; Kilander, Lena; Religa, Dorota; Wimo, Anders; Winblad, Bengt; Schott, Jonathan M; Blennow, Kaj; Eriksdotter, Maria; Zetterberg, Henrik // Brain: A Journal of Neurology;Sep2015, Vol. 138 Issue 9, p2716 

    Progressive cognitive decline in combination with a cerebrospinal fluid biomarker pattern of low levels of amyloid-β1-42 and high levels of total tau and phosphorylated tau is typical of Alzheimer's disease. However, several neurodegenerative disorders may overlap with Alzheimer's disease...

  • Alzheimer's research: Tau may provide early marker of disease.  // Geriatrics;Dec95, Vol. 50 Issue 12, p17 

    Reports that the diagnosis of Alzheimer's disease may possibly rest simply on the testing for a cellular protein known as tau in cerebrospinal fluid. Release of tau by dying neurons; Reaching of tau critical level very early in the disease process.

  • Amyloid Beta Protein and Tau in Cerebrospinal Fluid and Plasma as Biomarkers for Dementia: A Review of Recent Literature. Frankfort, Suzanne V.; Tulner, Linda R.; van Campen, Jos P. C. M.; Verbeek, Marcel M.; Jansen, Ren� W. M. M.; Beijnen, Jos H. // Current Clinical Pharmacology;May2008, Vol. 3 Issue 2, p123 

    This review addresses recent developments in amyloid � (A�), total tau (t-tau) and phosporylated tau (p-tau) protein analysis, in cerebrospinal fluid (CSF) and plasma as biomarkers for dementia. Recent research focused on the progression of patients with mild cognitive impairment (MCI)...

  • The cerebrospinal fluid biomarker profile in an HIV‑infected subject with Alzheimer's disease. Mäkitalo, Signar; Mellgren, Åsa; Borgh, Ellen; Kilander, Lena; Skillbäck, Tobias; Zetterberg, Henrik; Gisslén, Magnus // AIDS Research & Therapy;Jul2015, Vol. 12 Issue 1, p1 

    It is a challenge to differentiate between HIV-associated neurocognitive disorders (HAND) and other types of neurocognitive disease in the ageing HIV-infected population. Here we describe a 63 year old HIV-infected woman who had a history, neuropsychological test result, and PET examination...

  • 10: EARLY DIAGNOSIS FOR ALZHEIMER'S. McAULIFFE, KATHLEEN // Discover;Jan/Feb2011, Vol. 32 Issue 1, p32 

    The article discusses advances made in 2010 for diagnosis of Alzheimer's disease. Two techniques are described, one involving detection of a radioactive tracer that binds to amyloid plaque in the brains of Alzheimer's patients, and the other involving withdrawal of cerebrospinal fluid and...

  • Cerebrospinal Fluid Amyloid β42/Phosphorylated Tau Ratio Discriminates Between Alzheimer's Disease and Vascular Dementia. De Jong, Daniëlle; Jansen, René W. M. M.; Kremer, Berry P. H.; Verbeek, Marcel M. // Journals of Gerontology Series A: Biological Sciences & Medical ;Jul2006, Vol. 61 Issue 7, p755 

    Background. The differentiation of Alzheimer's disease (AD) from vascular dementia (VaD) is hampered by clinical diagnostic criteria with disappointing sensitivity and specificity. The objective of this study was to investigate whether cerebrospinal fluid (CSF) levels of total tau protein...

  • Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease. Noguchi-Shinohara, Moeko; Hamaguchi, Tsuyoshi; Nozaki, Ichiro; Sakai, Kenji; Yamada, Masahito // Journal of Neurology;Aug2011, Vol. 258 Issue 8, p1464 

    Total tau protein (t-tau) levels in cerebrospinal fluid (CSF) (CSF-tau) are markedly elevated in patients with Creutzfeldt-Jakob disease (CJD). Some CSF-tau may leak into the blood. We evaluated t-tau levels in serum (serum-tau) as a possible marker for the differential diagnosis of CJD from...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics